Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Biomarker; Brain tumor; Diagnosis; Meningioma; Molecular characterization; Prognosis; Recurrence; AKT1; v-Akt murine thymoma viral oncogene homolog 1; BAP1; BRCA1-associated protein 1; CDKN2A and B; Cyclin-dependent kinase inhibitor 2A and 2B; FAK; Focal
مقالات ISI پروتئین مرگ سلولی برنامه ریزی شده 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Nasopharyngeal carcinoma; Epstein-Barr virus; Immunotherapy; Cellular-based therapy; Vaccination; Head and neck cancer; DC; dendritic cell; NK; natural killer cell; CTL; cytotoxic T lymphocyte/cell; NPC; nasopharyngeal carcinoma; HLA; human leukocyte anti
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ARG-1; arginase 1; CCL-; CC motif chemokine ligand-; CXCL-; CX-C motif chemokine ligand-; CAF; cancer associated fibroblast; CO; carbon monoxide; CVB3; coxsackievirus B3; COX-2; cyclooxygenase-2; DC; dendritic cell; EAU; experimental autoimmune uveitis; E
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; APC; antigen presenting cell; APOBEC; apolipoprotein B mRNA editing enzyme catalytic polypeptide-like; BRCA1/2; breast cancer 1/2; BCSS; breast cancer specific survival; B2M; β-2-microglobulin; CAF; cancer associated fibroblast; CCL; chemokine ligand; CD
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ADAM; a disintegrin and metalloproteinase; APP; amyloid precursor protein; APC; antigen presenting cell; Aβ; β-amyloid; B7-H1; B7-homolog 1; CARD; caspase activation and recruitment domain; CCR; C-C chemokine receptor; CIM; C-protein induced myositis; C
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Primary immunodeficiency; malignancy; tumor predisposition; immune surveillance; pre-existing condition; ALL; Acute lymphoblastic leukemia; ALPS; Autoimmune lymphoproliferative syndrome; AT; Ataxia teleangiectasia; CHH; Cartilage-hair hypoplasia; CID; Com
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; mast cells; degranulation; Mas-related G protein-coupled receptor X2; IL-33; adhesion G protein-coupled receptor E2; tryptase; allergy; mastocytosis; ADGRE2; Adhesion G protein-coupled receptor E2; CPA3; Carboxypeptidase 3; CTMC; Connective tissue m
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; gene sequencing; immunology; immunotherapy; tumor mutations; CTL; cytotoxic T lymphocyte; ELISPOT; enzyme-linked ImmunoSpot; HLA; human leukocyte antigen; MHC; major histocompatibility complex; PD-1; programmed cell death protein 1; pMHC; peptide MHC;
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Ab; antibody; ACT; adoptive cell therapy; ANG; angiopoietin; ATP; adenosine triphosphate; BMDC; bone marrow derived cell; CA4P; combretastatin A phosphate; CAF; cancer-associated fibroblast; CCL2; C-C motif ligand 2; CD; cluster differentiation antigen; C
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ABVD; doxorubicin, bleomycin, vinblastine, dacarbazine; BEACOPP; bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone; FDG; [18F]-fludeoxyglucose; GHSG; German Hodgkin Study Group; MOPP; nitrogen mustard, vincristine,
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; 17-AAG; 17-(Allylamino)-17-demethoxygeldanamycin; 17-DMAG; 17-Dimethylaminoethylamino-17-demethoxygeldanamycin; AKT; v-akt murine thymoma viral oncogene homolog; APC; antigen presenting cell; ATM; Ataxia telangiectasia mutated; ATR; Ataxia telangiectasia
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; 5-ALA; 5-aminolevulinic acid; 5-FU; 5-fluorouracil; APC; antigen presenting cell; BCC; basal cell carcinoma; CAP; cold atmospheric plasma; CM; cutaneous malignant melanoma; CNP; cerium oxide nanoparticle; CNT; carbon nanotube; COX-2; cyclooxygenase II; CP
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; AE; adverse effect; APC; antigen-presenting cells; CI; confidence interval; CP; carboplatin and paclitaxel; CR; complete response; CTLA-4; cytotoxic T-lymphocyte-associated antigen-4; cuSCC; cutaneous squamous cell carcinoma; FDA; Food and Drug Administ
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; AAV; adeno-associated viruses; Ad6; adenovirus serotype 6; ABCB5Â +; ATP-binding cassette sub-family B member 5; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; APCs; antigen presenting cells; B7.1; (CD80) cluster of differentiation 80; BCG; Ba
T-cell receptor gene therapy - ready to go viral?
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; T-cell receptor; Gene therapy; Cancer; Immunotherapy; T cell; ACT; adoptive cell therapy; allo-SCT; allogeneic stem cell transplantation; APC; antigen-presenting cell; BLAST; basic local alignment search tool; CAR; chimeric antigen receptor; CTL; cytotoxi
Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; CTLA4; Cytotoxic T lymphocyte-associated antigen 4; DCs; Dendritic cells; IL-12; Interleukine-12; MDSCs; Myeloid-derived suppressor cells; NK cells; Natural killer cells; PAPs; Proapoptotic peptides; PD1; Programmed cell death protein 1; Tregs; Regulatory
Goodpasture's disease in a patient with advanced lung cancer treated with nivolumab: An autopsy case report
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Goodpasture's disease; Immune-related adverse events; Nivolumab; Programmed cell death protein 1;
Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; PD-1; IDO; Breast cancer; Tumor microenvironment (TME); Tumor-draining lymph nodes (TDLNs); TCGA dataset; PD-1; programmed cell death protein 1; IDO; indoleamine 2,3-dioxygenase; TME; tumor microenvironment; TDLNs; tumor-draining lymph nodes; APCs; antige
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; 9G8; serine and arginine rich splicing factor 7; AKT; AKT serine/threonine kinase; AR; androgen receptor; ARE; androgen response element; ARG1; arginase 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and rad3-related protein; BMDC; mous
Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ADCC; antibody dependent cell cytotoxicity; CD; cluster of differentiation; mAb; monoclonal antibody; CsA; cyclosporine; CTLA-4; T-lymphocyte antigen 4; GITR; glucocorticoid-induced tumor necrosis factor receptor (TNFR) family related gene; CCR4; C-C chem
Epigenetic mechanisms regulating T-cell responses
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Epigenetics; gene regulation; enhancer; promoter; chromatin accessibility; histone modifications; DNA methylation; transcription factor binding; T-cell development; T-cell function; T-cell exhaustion; regulatory T cells; tissue specificity; ATAC; Assay fo
Novel minor HLA DR associated antigens in type 1 diabetes
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; IM; Inflammatory myositis; MLH1; MutL homolog; MTIF3; Mitochondrial translational initiation factor 3; NAPPA Array; Nucleic acid programmable protein arrays; NUP50; Nucleoporin 50; PD-1; Programmed cell death protein 1; PDL1; Programmed cell death 1 ligan
MicroRNAs 15A and 16-1 Activate Signaling Pathways That Mediate Chemotaxis of Immune Regulatory B cells to Colorectal Tumors
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Immune Regulation; Tumor Immunosuppression; microRNA15A/16-1; Colon Cancer Model; AD; azoxymethane with dextran sodium sulfate; CAC; colitis-associated colorectal cancer; CRC; colorectal cancer; CXCL; chemokine (C-X-C motif) ligand; DSS; dextran sodium
Airway exposure initiates peanut allergy by involving the IL-1 pathway and T follicular helper cells in mice
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Follicular T cells; IL-4; IgE; allergy; peanut; IL-1; IL-33; BAL; Bronchoalveolar lavage; CTX; Cholera toxin; eGFP; Enhanced green fluorescent protein; FACS; Fluorescence-activated cell sorting; GC; Germinal center; IL-1RAcP; IL-1R-associated protein; IN;
Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Binimetinib (PubChem CID: 10288191); Cobimetinib (PubChem CID: 16222096); Dabrafenib (PubChem CID: 44462760); Encorafenib (PubChem CID: 50922675); Trametinib (PubChem CID: 11707110); Vemurafenib (PubChem CID: 42611257); ATC; adoptively transferred T cells
SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Stevens-Johnson; Toxic epidermal necrolysis; HLA; Networks; Pharmacogenomics; Pharmacovigilance; Electronic health record; T cells; Granulysin; ADR; Adverse drug reaction; AMT; Amniotic membrane transplantation; BSA; Body surface area; CPNDS; Canadian Pha
Programmed Cell Death Ligand 1 Expression in Non-Small-cell Lung Cancer Patients With Interstitial Lung Disease: A Matched Case-control Study
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Checkpoint inhibitor; Immunohistochemical analysis; Interstitial pneumonia; Programmed cell death protein 1; PD-L1;
Optimizing conventional DMARD therapy for Sjögren's syndrome
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; 6-MP; 6-mercaptopurine; 6-T-GTP; 6-thioguanine triphosphate; ABT; abatacept; Ach; acetylcholine; ALAT; alanine amino transferase; AZA; azathioprine; BAFF; B cell activating factor; Bcl-6; B cell lymphoma 6; bDMARDs; biological disease modifying antirheuma
Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; X-linked lymphoproliferative disease; T-cell gene therapy; follicular helper T cells; T-cell cytotoxicity; BV; Brilliant Violet; CTL; Cytotoxic T lymphocyte; HLH; Hemophagocytic lymphohistiocytosis; HSCT; Hematopoietic stem cell transplantation; HVS; Herp
PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; BLI; bioluminescence imaging; BSA; bovine serum albumin; CTL; cytotoxic T lymphocytes; CRISPR/Cas; Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR associated nucleases; DEGs; differently expressed genes; DMEM; Dulbecco's modified Eagle's
TGFβ pathway inhibition in the treatment of non-small cell lung cancer
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ALK; Anaplastic leukemia kinase; CAF; Cancer-associated fibroblast; EGFR; Epidermal growth factor receptor; EMT; Epithelial-to-mesenchymal transition; MSC; Mesenchymal stem cell; NK Cell; Natural killer cell; NSCLC; Non-small cell lung cancer; OS; Overall
CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; CD40 agonist; PD-1 antagonist; Chronic infection; CTL exhaustion; mTORC1 pathway; CTL; cytotoxic T lymphocytes; DT; diphtheria toxin; DC; dendritic cell; LCMV; lymphocytic choriomeningitis virus; OVA; ovalbumin; PD-1; programmed cell death protein 1; PD-L
CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ACT; adoptive cell therapy; ADC; adenocarcinoma; ALK; anaplastic lymphoma kinase; CAF; cancer-associated fibroblast; CAR; chimeric antigen receptor; CEA; carcinoembryonic antigen; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DNR; dominant negative
Hematologic neoplasms: Dendritic cells vaccines in motion
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; DCs; dendritic cells; TAA; tumor-associated antigens; APC; antigen presenting cells; mDCs; myeloid dendritic cells; pDCs; plasmacytoid dendritic cells; HLA; human leukocyte antigen; Ag Antigens; abs antibodies; PBMCs; peripheral blood mononuclear cells; G
Analysis of non-small cell lung cancer microenvironment indicates preponderance of T cell exhaustion marker expression
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; CTLA4; cytotoxic T-lymphocyte-associated protein 4; LAG3; lymphocyte activated gene 3; PD-1; programmed cell death protein 1; CFSE; carboxyfluorescein succinimidyl ester; CD25 neg; CD25Dep cells; Lung cancer; Microenvironment; T cell; Exhaustion marker;
Chimeric antigen receptor T-cells for B-cell malignancies
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; ALL; acute lymphoblastic leukemia; B-ALL; B-cell acute lymphoblastic leukemia; CAR-T; chimeric antigen receptor T-cell; CAR; chimeric antigen receptor; CD; cluster of differentiation; CHOP; Children's Hospital of Philadelphia; CLL; chronic lymphocytic leu
Human regulatory B cells control the TFH cell response
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Regulatory B cells; follicular T helper cells; IL-12; IL-21; antibody production; humoral immune response; Bcl-6; B-cell lymphoma 6; Breg; Regulatory B; DC; Dendritic cell; Foxp3; Forkhead box P3; GC; Germinal center; ICAM; Intercellular adhesion molecule
Development of CAR T cells designed to improve antitumor efficacy and safety
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; 28z; CD28 + CD3ζ; 4-1BBL; 4-1BB ligand; B-ALL; B cell acute lymphatic leukemia; BBz; 4-1BB + CD3ζ; CAR; chimeric antigen receptor; CD40L; CD40 ligand; CRS; cytokine release syndrome; CTLA-4; cytotoxic T-lymphocyte associated protein 4; DCs; dendriti
Follicular helper T cells mediate IgE antibody response to airborne allergens
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Follicular T cells; IL-4; IgE; allergy; allergens; TH2 cells; APC; Antigen-presenting cell; BAL; Bronchoalveolar lavage; eGFP; Enhanced green fluorescent protein; FACS; Fluorescence-activated cell sorting; GC; Germinal center; HDM; House dust mite; ICOS;
HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; Immunotoxicology; Immunotoxicity; Immunomodulation; Immunosuppression; Carcinogenicity; Cancer; Risk assessment; CTL; cytotoxic T-lymphocytes; EBV; Epstein-Barr virus; FDA; Food and Drug Administration; HESI; Health and Environmental Sciences Institute;
Nasal IL-4+CXCR5+CD4+ T follicular helper cell counts correlate with local IgE production in eosinophilic nasal polyps
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; B cell; ectopic lymphoid structure; eosinophil; IgE; IL-4; nasal polyp; T follicular helper cell; Bcl-6; Transcription factor B-cell lymphoma 6; Bm; B mature; CRSwNP; Chronic rhinosinusitis with nasal polyps; CSR; Class-switch recombination; FACS; Fluores
Increased, but Functionally Impaired, CD14+ HLA-DR-/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; iTreg; induced regulatory T cell; MDSC; myeloid-derived suppressor cell; Mo-MDSC; monocytic myeloid-derived suppressor cell; PBMC; peripheral blood mononuclear cell; PD-1; programmed cell death protein 1; PD-L1; programmed death-ligand 1; ROS; reactive ox
Microenvironment interactions and B-cell receptor signaling in Chronic Lymphocytic Leukemia: Implications for disease pathogenesis and treatment
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; APRIL; a proliferation-inducing ligand; ATM; ataxia telangiectasia mutated; BAFF; B-cell activating factor; BAFFR; BAFF receptor; BAG6; BCL2-associated athanogene 6; BCMA; B-cell maturation antigen; BCL2; B-cell lymphoma 2; BCR; B cell receptor; bFGF; bas
Research ArticleRestoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation
Keywords: پروتئین مرگ سلولی برنامه ریزی شده 1; HBV; hepatitis B virus; HBeAg; hepatitis B e antigen; HIV; human immunodeficiency virus; PD-1; programmed cell death protein 1; CTLA-4; cytotoxic T-lymphocyte protein 4; 2B4; natural killer cell receptor 2B4; BTLA; B and T lymphocyte attenuator; Tim-3; T